Bone & Soft Tissue Tumors Program
If your child is diagnosed with a tumor, you want one of the best care teams managing his or her treatment. At Stanford Children’s Health, our highly skilled experts lead a comprehensive care team that provides state-of-the-art treatment for benign (non-cancerous) or malignant (cancerous) bone and soft tissue tumors.
Our bone and soft tissue tumors program brings together a multidisciplinary team of physicians and experts, so your child will benefit from coordinated care across a range of specialties, including oncology, radiation oncology, radiology and pathology.
Benign (noncancerous) tumor treatment
If your child’s bone or soft tissue tumor is benign, or noncancerous, our team of nationally recognized pediatric orthopedic surgeons will treat it safely and effectively. The most common types of benign bone tumors include osteoblastoma, osteoid osteoma and chondroblastoma.
We can provide access to advanced techniques that are unavailable at most U.S. hospitals, including PET/MRI imaging and high-intensity focused ultrasound. In some cases, these techniques can remove the tumor without the need for traditional surgery.
We also offer all the latest surgical procedures and treatments, including the following:
- Minimally invasive surgery
- Complex bone grafting, including vascularized grafts and allografting
- Image-guided tumor resection
- Limb salvage and joint-preserving procedures
- Customized implants
- Prostheses that “grow” with your child
- Advanced implants such as compress technology
- Rotationplasty
Malignant (cancerous) sarcoma treatment
If your child has a sarcoma—a malignant or cancerous bone or soft tissue tumor—he or she will be treated by a multidisciplinary team, including oncologists who will treat the tumor with chemotherapy and/or radiation and orthopedic surgeons who may remove the tumor. Some of the most common types of sarcoma in children include Ewing sarcoma, osteosarcoma and rhabdomyosarcoma. Our team has experience treating these and the dozens of rarer types of sarcoma in children.
We offer cutting-edge clinical trials to treat sarcoma, and our physicians have experience leading trials and developing effective new treatments that are now used around the world. Under the leadership of Dr. Sheri Spunt, a world-renowned sarcoma expert, our physicians continually research ways to improve outcomes and bring them to our patients.
We are also part of the National Cancer Institute–designated Stanford Cancer Institute, and our team works with several worldwide groups dedicated to advancing treatments and serving patients with tumors and their families, including the Children’s Oncology Group, the Musculoskeletal Tumor Society, and the Connective Tissue Oncology Society.
